BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26989694)

  • 1. Quiescent and Active Tear Protein Profiles to Predict Vernal Keratoconjunctivitis Reactivation.
    Micera A; Di Zazzo A; Esposito G; Sgrulletta R; Calder VL; Bonini S
    Biomed Res Int; 2016; 2016():9672082. PubMed ID: 26989694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
    Leonardi A; Jose PJ; Zhan H; Calder VL
    Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell factor in the tear fluid of vernal keratoconjunctivitis patients.
    Nakatani S; Ebihara N; Murakami A
    Jpn J Ophthalmol; 2007; 51(6):474-6. PubMed ID: 18158601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of hemopexin in tear film and conjunctival macrophages with vernal keratoconjunctivitis.
    Pong JC; Chu CY; Li WY; Tang LY; Li L; Lui WT; Poon TC; Rao SK; Lam DS; Wang CC; Pang CP
    Arch Ophthalmol; 2011 Apr; 129(4):453-61. PubMed ID: 21482871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis.
    Uchio E; Ono SY; Ikezawa Z; Ohno S
    Clin Exp Allergy; 2000 Jan; 30(1):103-9. PubMed ID: 10606937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis.
    Leonardi A; Borghesan F; DePaoli M; Plebani M; Secchi AG
    Exp Eye Res; 1998 Jul; 67(1):105-12. PubMed ID: 9702183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis.
    Shoji J; Inada N; Sawa M
    Jpn J Ophthalmol; 2006; 50(3):195-204. PubMed ID: 16767372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.
    Leonardi A; Sathe S; Bortolotti M; Beaton A; Sack R
    Allergy; 2009 May; 64(5):710-7. PubMed ID: 19220217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1- and Th2-type cytokines in chronic ocular allergy.
    Leonardi A; Fregona IA; Plebani M; Secchi AG; Calder VL
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1240-5. PubMed ID: 16538446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis.
    Shoji J; Inada N; Sawa M
    Jpn J Ophthalmol; 2009 Mar; 53(2):92-99. PubMed ID: 19333691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
    Oray M; Toker E
    Cornea; 2013 Aug; 32(8):1149-54. PubMed ID: 23676782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.
    Hu Y; Matsumoto Y; Dogru M; Okada N; Igarashi A; Fukagawa K; Tsubota K; Fujishima H
    Allergy; 2007 Aug; 62(8):917-25. PubMed ID: 17620070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vernal keratoconjunctivitis activity induces decrease of ocular surface CD14, TLR-4 and TLR-9 expression.
    Sacchetti M; Nebbioso M; Segatto M; Abicca I; Bruscolini A; Zicari AM; Lambiase A
    Eur J Ophthalmol; 2022 Jul; 32(4):2274-2281. PubMed ID: 34609157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear osteopontin levels in patients with allergic conjunctival diseases.
    Uchio E; Matsuura N; Kadonosono K; Ohno S; Uede T
    Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):924-8. PubMed ID: 12486515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
    Akman A; IrkeƧ M; Orhan M
    Eye (Lond); 1998; 12 ( Pt 2)():291-5. PubMed ID: 9683957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics.
    Leonardi A; Palmigiano A; Mazzola EA; Messina A; Milazzo EM; Bortolotti M; Garozzo D
    Allergy; 2014 Feb; 69(2):254-60. PubMed ID: 24329893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis.
    Fujishima H; Takeyama M; Takeuchi T; Saito I; Tsubota K
    Clin Exp Allergy; 1997 Apr; 27(4):372-8. PubMed ID: 9146929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases.
    Fujishima H; Okada N; Matsumoto K; Fukagawa K; Igarashi A; Matsuda A; Ono J; Ohta S; Mukai H; Yoshikawa M; Izuhara K
    J Allergy Clin Immunol; 2016 Aug; 138(2):459-467.e2. PubMed ID: 26964692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histaminase activity in patients with vernal keratoconjunctivitis.
    Abelson MB; Leonardi AA; Smith LM; Fregona IA; George MA; Secchi AG
    Ophthalmology; 1995 Dec; 102(12):1958-63. PubMed ID: 9098303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.